Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 06, 2026 13:09 ET | Source: BCC Research LLC

Explosive CAGR Trends Reshape Global Markets: Energy Transition and Next-Gen Medicine Accelerate

From renewable energy breakthroughs to climate tech innovations and advanced cancer treatments, these sectors are not just growing, but redefining future.
January 06, 2026 10:00 ET | Source: Dewpoint Therapeutics

Dewpoint Therapeutics Launches Initiative to Build Viral Condensate Phenomics Atlas for HPV

Dewpoint Therapeutics launches Gates Foundation-funded initiative to build and share viral condensate phenomics atlas for HPV.
January 06, 2026 04:00 ET | Source: Hummingbird Bioscience

Hummingbird Bioscience Announces First Patient Dosed in Phase I Clinical Trial of HMBD-501 in Advanced HER3-Expressing Solid Malignancies

Hummingbird Bioscience today announced that the first patient has been dosed in a Phase I clinical trial of HMBD-501.
January 05, 2026 16:05 ET | Source: Revolution Medicines, Inc.

Revolution Medicines to Present at 44th Annual J.P. Morgan Healthcare Conference

REDWOOD CITY, Calif., Jan. 05, 2026 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a late-stage clinical oncology company developing targeted therapies for patients with RAS-addicted...
January 05, 2026 05:00 ET | Source: ProPhase Labs, Inc.

ProPhase Labs Provides Update on Convertible Debt Conversions, Capital Structure, and Underlying Asset Value

UNIONDALE, NY, Jan. 05, 2026 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (OTC: PRPH) today provided an update to shareholders regarding recent trading activity, its capital structure, and the...
January 05, 2026 01:16 ET | Source: Burning Rock Biotech Limited

Burning Rock Announces Founder’s Purchase of Its ADSs

Burning Rock Announces Founder’s Purchase of Its ADSs
December 29, 2025 06:00 ET | Source: Greenwich LifeSciences, Inc.

Greenwich LifeSciences Extends Lock-up of Directors and Officers to September 30, 2026

STAFFORD, Texas, Dec. 29, 2025 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial,...
December 22, 2025 23:04 ET | Source: Burning Rock Biotech Limited

Burning Rock Announces Results of 2025 Annual General Meeting

Burning Rock Announces Results of 2025 Annual General Meeting
December 22, 2025 07:00 ET | Source: Propanc Biopharma, Inc.

Propanc Biopharma Publishes Impact of Proenzymes on Pancreatic Ductal Adenocarcinoma Fibroblasts in Peer Reviewed Journal

Our findings demonstrate that PRP exerts multifaceted effects specifically over the cancer associated fibroblasts (CAFs) population and tumor cells.
December 20, 2025 11:46 ET | Source: Crosetto Foundation for the Reduction of Cancer Deaths

The 3D-Flow Architecture Breakthrough: A Universal, Scalable Digital Processor for Real-Time Pattern Recognition in High-Rate Data Streams — A Platform to Save Millions of Lives and Billions of Euros

From Physics to Healing: The same tech used to find particles can find cancer early. Why is this life-saving leap being suppressed?